Search
Filanesib
go.drugbank.com/drugs/DB06040InvestigationalFilanesib is a potent Kinesin Spindle Protein (KSP) inhibitor that caused marked tumor regression in preclinical models of human solid tumors and human leukemias, often leading to durable responses.
Asparagine
go.drugbank.com/drugs/DB00174ApprovedNutraceuticalWithdrawnA non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from aspartic acid and ammonia by asparagine synthetase. (From Concise Encyclopedia Biochemistry and M...
Piperine
go.drugbank.com/drugs/DB12582InvestigationalBioperine has been used in trials studying the treatment of Multiple Myeloma and Deglutition Disorders.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesLexacalcitol
go.drugbank.com/drugs/DB03451ExperimentalThese are compounds containing a secosteroid backbone, usually secoergostane or secocholestane. It is known to target the vitamin D3 receptor.
Phenamazoline
go.drugbank.com/drugs/DB19509ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Phenamazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Tinazoline
go.drugbank.com/drugs/DB20310ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Tinazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Nemazoline
go.drugbank.com/drugs/DB21115ExperimentalThe usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.
Ontuxizumab
go.drugbank.com/drugs/DB16270InvestigationalOntuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1).
Elzasonan
go.drugbank.com/drugs/DB18969InvestigationalElzasonan is under investigation in clinical trial NCT00275197 (A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive
Mevidalen
go.drugbank.com/drugs/DB19034InvestigationalMevidalen is under investigation in clinical trial NCT03305809 (A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or